{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:49:57Z","timestamp":1791301797697,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:00:00Z","timestamp":1363392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1476-511x-12-36","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T21:14:14Z","timestamp":1363468454000},"source":"Crossref","is-referenced-by-count":30,"title":["Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine"],"prefix":"10.1186","volume":"12","author":[{"given":"Johannes F","family":"Fahrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Elaine","family":"Hardman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,16]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11912-011-0188-6","volume":"13","author":"JC Riches","year":"2011","unstructured":"Riches JC, Ramsay AG, Gribben JG: Chronic lymphocytic leukemia: an update on biology and treatment. Curr Oncol Rep. 2011, 13: 379-385. 10.1007\/s11912-011-0188-6","journal-title":"Curr Oncol Rep"},{"key":"861_CR2","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1182\/blood.V84.10.3440.3440","volume":"84","author":"R Silber","year":"1994","unstructured":"Silber R, Degar B, Costin D, Newcomb EW, Mani M: Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood. 1994, 84: 3440-3446.","journal-title":"Blood"},{"key":"861_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2165\/00003495-200363100-00003","volume":"63","author":"F Schriever","year":"2003","unstructured":"Schriever F, Huhn D: New directions in the diagnosis and treatment of chronic lymphocytic leukaemia. Drugs. 2003, 63: 953-969. 10.2165\/00003495-200363100-00003","journal-title":"Drugs"},{"key":"861_CR4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ajcn\/54.3.438","volume":"54","author":"AP Simopoulos","year":"1991","unstructured":"Simopoulos AP: Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991, 54: 438-463.","journal-title":"Am J Clin Nutr"},{"key":"861_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ps\/79.7.961","volume":"79","author":"AP Simopoulos","year":"2000","unstructured":"Simopoulos AP: Human requirement for N-3 polyunsaturated fatty acids. Poult Sci. 2000, 79: 961-970.","journal-title":"Poult Sci"},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","volume":"56","author":"AP Simopoulos","year":"2002","unstructured":"Simopoulos AP: The importance of the ratio of omega-6\/omega-3 essential fatty acids. Biomed Pharmacother. 2002, 56: 365-379. 10.1016\/S0753-3322(02)00253-6","journal-title":"Biomed Pharmacother"},{"key":"861_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<578::AID-IJC14>3.0.CO;2-5","volume":"75","author":"E Germain","year":"1998","unstructured":"Germain E, Chajes V, Cognault S, Lhuillery C, Bougnoux P: Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer. 1998, 75: 578-583. 10.1002\/(SICI)1097-0215(19980209)75:4<578::AID-IJC14>3.0.CO;2-5","journal-title":"Int J Cancer"},{"key":"861_CR8","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/0006-2952(93)90447-5","volume":"45","author":"JE Kinsella","year":"1993","unstructured":"Kinsella JE, Black JM: Effects of polyunsaturated fatty acids on the efficacy of antineoplastic agents toward L5178Y lymphoma cells. Biochem Pharmacol. 1993, 45: 1881-1887. 10.1016\/0006-2952(93)90447-5","journal-title":"Biochem Pharmacol"},{"key":"861_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF02535165","volume":"24","author":"CE Borgeson","year":"1989","unstructured":"Borgeson CE, Pardini L, Pardini RS, Reitz RC: Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes. Lipids. 1989, 24: 290-295. 10.1007\/BF02535165","journal-title":"Lipids"},{"key":"861_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/01635589709514554","volume":"28","author":"Y Shao","year":"1997","unstructured":"Shao Y, Pardini L, Pardini RS: Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide. Nutr Cancer. 1997, 28: 63-73. 10.1080\/01635589709514554","journal-title":"Nutr Cancer"},{"key":"861_CR11","first-page":"2041","volume":"7","author":"WE Hardman","year":"2001","unstructured":"Hardman WE, Avula CP, Fernandes G, Cameron IL: Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res. 2001, 7: 2041-2049.","journal-title":"Clin Cancer Res"},{"key":"861_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/07357907.2012.743553","volume":"31","author":"JF Fahrmann","year":"2013","unstructured":"Fahrmann JF, Ballester OF, Ballester G, Witte TR, Salazar AJ: Inhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty Acids. Cancer Invest. 2013, 31: 29-43.","journal-title":"Cancer Invest"},{"key":"861_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF00735923","volume":"32","author":"C Muller","year":"1993","unstructured":"Muller C, Chatelut E, Gualano V, De Forni M, Huguet F: Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion. Cancer Chemother Pharmacol. 1993, 32: 379-384. 10.1007\/BF00735923","journal-title":"Cancer Chemother Pharmacol"},{"key":"861_CR14","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1200\/JCO.1999.17.5.1574","volume":"17","author":"JM Foran","year":"1999","unstructured":"Foran JM, Oscier D, Orchard J, Johnson SA, Tighe M: Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with \u201clow-grade\u201d non-Hodgkin\u2019s lymphoma and B-cell chronic lymphocytic leukemia. J Clin Oncol. 1999, 17: 1574-1579.","journal-title":"J Clin Oncol"},{"key":"861_CR15","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00280-011-1745-2","volume":"68","author":"R Guilhaumou","year":"2011","unstructured":"Guilhaumou R, Solas C, Bourgarel-Rey V, Quaranta S, Rome A: Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity. Cancer Chemother Pharmacol. 2011, 68: 1633-1638. 10.1007\/s00280-011-1745-2","journal-title":"Cancer Chemother Pharmacol"},{"key":"861_CR16","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1182\/blood.V98.8.2319","volume":"98","author":"M Leporrier","year":"2001","unstructured":"Leporrier M, Chevret S, Cazin B, Boudjerra N, Feugier P: Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood. 2001, 98: 2319-2325. 10.1182\/blood.V98.8.2319","journal-title":"Blood"},{"key":"861_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3747\/co.19.1064","volume":"19","author":"R Van der Jagt","year":"2012","unstructured":"Van der Jagt R, Laneuville P, Macdonald D, Stewart D, Christofides A: A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma. Curr Oncol. 2012, 19: 160-168.","journal-title":"Curr Oncol"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1172\/JCI64101","volume":"122","author":"G Gaidano","year":"2012","unstructured":"Gaidano G, Foa R, Dalla-Favera R: Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest. 2012, 122: 3432-3438. 10.1172\/JCI64101","journal-title":"J Clin Invest"},{"key":"861_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jss.2006.10.024","volume":"139","author":"T Dekoj","year":"2007","unstructured":"Dekoj T, Lee S, Desai S, Trevino J, Babcock TA: G2\/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model. J Surg Res. 2007, 139: 106-112. 10.1016\/j.jss.2006.10.024","journal-title":"J Surg Res"},{"key":"861_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jprot.2008.09.001","volume":"71","author":"P Casado","year":"2009","unstructured":"Casado P, Prado MA, Zuazua-Villar P, Del Valle E, Artime N: Microtubule interfering agents and KSP inhibitors induce the phosphorylation of the nuclear protein p54(nrb), an event linked to G2\/M arrest. J Proteomics. 2009, 71: 592-600. 10.1016\/j.jprot.2008.09.001","journal-title":"J Proteomics"},{"key":"861_CR21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0026-895X(25)09073-X","volume":"49","author":"YH Ling","year":"1996","unstructured":"Ling YH, el-Naggar AK, Priebe W, Perez-Soler R: Cell cycle-dependent cytotoxicity, G2\/M phase arrest, and disruption of p34cdc2\/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol. 1996, 49: 832-841.","journal-title":"Mol Pharmacol"},{"key":"861_CR22","first-page":"3512","volume":"8","author":"AK Tyagi","year":"2002","unstructured":"Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R: Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Clin Cancer Res. 2002, 8: 3512-3519.","journal-title":"Clin Cancer Res"},{"key":"861_CR23","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.3390\/molecules17043736","volume":"17","author":"L Zhang","year":"2012","unstructured":"Zhang L, Ruan J, Yan L, Li W, Wu Y: Xanthatin induces cell cycle arrest at G2\/M checkpoint and apoptosis via disrupting NF-kappaB pathway in A549 non-small-cell lung cancer cells. Molecules. 2012, 17: 3736-3750. 10.3390\/molecules17043736","journal-title":"Molecules"},{"key":"861_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1055\/s-0031-1298481","volume":"78","author":"L Zhang","year":"2012","unstructured":"Zhang L, Tao L, Ruan J, Li W, Wu Y: Xanthatin induces G2\/M cell cycle arrest and apoptosis in human gastric carcinoma MKN-45 cells. Planta Med. 2012, 78: 890-895.","journal-title":"Planta Med"},{"key":"861_CR25","doi-asserted-by":"publisher","first-page":"e10296","DOI":"10.1371\/journal.pone.0010296","volume":"5","author":"KS Kang","year":"2010","unstructured":"Kang KS, Wang P, Yamabe N, Fukui M, Jay T: Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One. 2010, 5: e10296- 10.1371\/journal.pone.0010296","journal-title":"PLoS One"},{"key":"861_CR26","first-page":"1053","volume":"77","author":"ME Begin","year":"1986","unstructured":"Begin ME, Ells G, Das UN, Horrobin DF: Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 1986, 77: 1053-1062.","journal-title":"J Natl Cancer Inst"},{"key":"861_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jnci\/80.3.188","volume":"80","author":"ME Begin","year":"1988","unstructured":"Begin ME, Ells G, Horrobin DF: Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst. 1988, 80: 188-194. 10.1093\/jnci\/80.3.188","journal-title":"J Natl Cancer Inst"},{"key":"861_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1476-511X-10-159","volume":"10","author":"UN Das","year":"2011","unstructured":"Das UN, Madhavi N: Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro. Lipids Health Dis. 2011, 10: 159- 10.1186\/1476-511X-10-159","journal-title":"Lipids Health Dis"},{"key":"861_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1476-511X-9-31","volume":"9","author":"TR Witte","year":"2010","unstructured":"Witte TR, Salazar AJ, Ballester OF, Hardman WE: RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials. Lipids Health Dis. 2010, 9: 31- 10.1186\/1476-511X-9-31","journal-title":"Lipids Health Dis"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-12-36.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1476-511X-12-36\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-12-36.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:49:34Z","timestamp":1745974174000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-12-36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-12-36","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,16]]},"article-number":"36"}}